September 26, 2024

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category
Go back

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and sustainable innovation.

Every year, the DQS Sustainability Awards recognize companies that are pioneers in sustainability. It is one of the most important awards in the field of sustainability, recognizing companies, regardless of their size, for their innovative approaches to promoting environmental protection and social responsibility. This nomination is not only a recognition for Terra Trust, but underscores how necessary sustainable solutions have become in all areas of life, including the healthcare industry.

For Terra Trust, this nomination symbolizes much more than just a recognition of their technical innovation. It highlights the growing importance of environmental protection in a sector traditionally characterized by plastic waste and environmentally harmful disposables. Their product represents a new generation of pregnancy tests that protect the environment without compromising on quality or accuracy.

More Information in German / Original News:

Sustainability Award 2024 TerraTrustDownload

Our latest News

discover more
CST Announces Availability of GMP-Grade CAR Linker Antibodies for CAR-T Cell Enrichment and Detection in Clinical Manufacturing and QC

CST Announces Availability of GMP-Grade CAR Linker Antibodies for CAR-T Cell Enrichment and Detection in Clinical Manufacturing and QC

Danvers, MA, USA, October 7, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the availability for purchase of GMP-grade recombinant monoclonal antibody conjugates targeting the G4S linker of scFv-based chimeric antigen receptors (CARs) for CAR-T cell enrichment and detection in cell therapy manufacturing […]

read more
Wittenstein Biointelligence Prize: AwardedBacteria Produce Bioplastic; Living Nerve Cells Process Information

Wittenstein Biointelligence Prize: AwardedBacteria Produce Bioplastic; Living Nerve Cells Process Information

The Wittenstein Biointelligence Prize was awarded on Tuesday evening at the third Biointelligence Congress. Biotechnologist Moritz Bross won in the “Individual” category, while Cortical Labs was honored in the “Company” category. With this prize, the Wittenstein Foundation recognizes innovative, practical, and sustainable solutions that combine biology with information and production technology. Full Text in German […]

read more
Synthetic Cells: Function Through Mutation

Synthetic Cells: Function Through Mutation

Just a few genetic changes transform simple RNA droplets into cell-like structures that can move and take up cargo A small number of random genetic mutations cause simple RNA droplets to transform into cell-like structures. In this process, they form cavities, can move and are able to take up cargo. This has been demonstrated through […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp